Trial · NCT00413166
Adverse events87
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 87
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Infection | Infections and infestations | ATRA + ATO: Low Risk (WBC<10,000) | 5 | 57 | 5 |
| other | Infection | Infections and infestations | ATRA+ATO+IDA: High Risk (WBC >10,000) | 0 | 5 | 0 |
| other | Infection | Infections and infestations | ATO+ATRA+GO | 1 | 16 | 1 |
| serious | Appendectomy | Gastrointestinal disorders | ATRA + ATO: Low Risk (WBC<10,000) | 1 | 57 | 1 |
| serious | Appendectomy | Gastrointestinal disorders | ATRA+ATO+IDA: High Risk (WBC >10,000) | 0 | 5 | 0 |
| serious | Appendectomy | Gastrointestinal disorders | ATO+ATRA+GO | 0 | 16 | 0 |
| serious | Cardiac Troponin I | Cardiac disorders | ATRA + ATO: Low Risk (WBC<10,000) | 1 | 57 | 1 |
| serious | Cardiac Troponin I | Cardiac disorders | ATRA+ATO+IDA: High Risk (WBC >10,000) | 0 | 5 | 0 |
| serious | Cardiac Troponin I | Cardiac disorders | ATO+ATRA+GO | 0 | 16 | 0 |
| serious | Chest Pain | Cardiac disorders | ATRA + ATO: Low Risk (WBC<10,000) | 1 | 57 | 1 |
| serious | Chest Pain | Cardiac disorders | ATRA+ATO+IDA: High Risk (WBC >10,000) | 0 | 5 | 0 |
| serious | Chest Pain | Cardiac disorders | ATO+ATRA+GO | 0 | 16 | 0 |
| serious | Depressed level of Consciousness | Nervous system disorders | ATRA + ATO: Low Risk (WBC<10,000) | 1 | 57 | 1 |
| serious | Depressed level of Consciousness | Nervous system disorders | ATRA+ATO+IDA: High Risk (WBC >10,000) | 0 | 5 | 0 |
| serious | Depressed level of Consciousness | Nervous system disorders | ATO+ATRA+GO | 0 | 16 | 0 |
| serious | Elevated Transaminases | Metabolism and nutrition disorders | ATRA + ATO: Low Risk (WBC<10,000) | 1 | 57 | 2 |
| serious | Elevated Transaminases | Metabolism and nutrition disorders | ATRA+ATO+IDA: High Risk (WBC >10,000) | 2 | 5 | 4 |
| serious | Elevated Transaminases | Metabolism and nutrition disorders | ATO+ATRA+GO | 0 | 16 | 0 |
| serious | Elevated Amylase | Metabolism and nutrition disorders | ATRA + ATO: Low Risk (WBC<10,000) | 1 | 57 | 1 |
| serious | Elevated Amylase | Metabolism and nutrition disorders | ATRA+ATO+IDA: High Risk (WBC >10,000) | 0 | 5 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00413166/events